Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Galit Alter

Showing results (401-410 of 535) with videos related to

Pageof 54
Sort By:
Nature Communications|March 6, 2021
Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus MacaquesAnthony M Cadena, John D Ventura, Peter Abbink, et al.
Circulation|January 4, 2023
Circulating Spike Protein Detected in Post-COVID-19 mRNA Vaccine MyocarditisLael M Yonker, Zoe Swank, Yannic C Bartsch, et al.
Plos Biology|May 5, 2022
Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primatesDaniel Y Zhu, Matthew J Gorman, Dansu Yuan, et al.
Journal of Virology|March 30, 2012
A nonfucosylated variant of the anti-HIV-1 monoclonal antibody b12 has enhanced FcγRIIIa-mediated antiviral activity in vitro but does not improve protection against mucosal SHIV challenge in macaquesBrian Moldt, Mami Shibata-Koyama, Eva G Rakasz, et al.
Plos Medicine|November 18, 2015
Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South AfricaAngelique Hölzemer, Christina F Thobakgale, Camilo A Jimenez Cruz, et al.
JCI Insight|January 11, 2021
Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022Caroline Atyeo, Matthew D Slein, Stephanie Fischinger, et al.
Cell|June 18, 2019
Fc Glycan-Mediated Regulation of Placental Antibody TransferMadeleine F Jennewein, Ilona Goldfarb, Sepideh Dolatshahi, et al.
Immunity|August 14, 2020
Distinct Early Serological Signatures Track with SARS-CoV-2 SurvivalCaroline Atyeo, Stephanie Fischinger, Tomer Zohar, et al.
Medrxiv : the Preprint Server for Health Sciences|September 26, 2025
A phase 1 randomized, placebo-controlled trial of a combination typhoid and non-typhoidal <i>Salmonella</i> polysaccharide conjugate vaccineWilbur H Chen, Robin S Barnes, Michael J Sikorski, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
Early cross-coronavirus reactive signatures of protective humoral immunity against COVID-19Paulina Kaplonek, Chuangqi Wang, Yannic Bartsch, et al.
Pageof 54

Showing results (401-410 of 535) with videos related to

Sort By:
Pageof 54
Nature Communications|March 6, 2021
Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus MacaquesAnthony M Cadena, John D Ventura, Peter Abbink, et al.
Circulation|January 4, 2023
Circulating Spike Protein Detected in Post-COVID-19 mRNA Vaccine MyocarditisLael M Yonker, Zoe Swank, Yannic C Bartsch, et al.
Plos Biology|May 5, 2022
Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primatesDaniel Y Zhu, Matthew J Gorman, Dansu Yuan, et al.
Journal of Virology|March 30, 2012
A nonfucosylated variant of the anti-HIV-1 monoclonal antibody b12 has enhanced FcγRIIIa-mediated antiviral activity in vitro but does not improve protection against mucosal SHIV challenge in macaquesBrian Moldt, Mami Shibata-Koyama, Eva G Rakasz, et al.
Plos Medicine|November 18, 2015
Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South AfricaAngelique Hölzemer, Christina F Thobakgale, Camilo A Jimenez Cruz, et al.
JCI Insight|January 11, 2021
Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022Caroline Atyeo, Matthew D Slein, Stephanie Fischinger, et al.
Cell|June 18, 2019
Fc Glycan-Mediated Regulation of Placental Antibody TransferMadeleine F Jennewein, Ilona Goldfarb, Sepideh Dolatshahi, et al.
Immunity|August 14, 2020
Distinct Early Serological Signatures Track with SARS-CoV-2 SurvivalCaroline Atyeo, Stephanie Fischinger, Tomer Zohar, et al.
Medrxiv : the Preprint Server for Health Sciences|September 26, 2025
A phase 1 randomized, placebo-controlled trial of a combination typhoid and non-typhoidal <i>Salmonella</i> polysaccharide conjugate vaccineWilbur H Chen, Robin S Barnes, Michael J Sikorski, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
Early cross-coronavirus reactive signatures of protective humoral immunity against COVID-19Paulina Kaplonek, Chuangqi Wang, Yannic Bartsch, et al.
Pageof 54